Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Mumbai Tragedy: Speeding Car Damages 15 Vehicles, Injures 2 In Powai; Senior Citizen Driver Booked
Bombay HC Says Plea Seeking Probe Against Uddhav Thackeray, Family Over Disproportionate Assets Not Maintainable
Maharashtra Deputy CM Eknath Shinde Assures Victory For Mahayuti And Citizens’ Rights In Bhiwandi Elections
.jpeg)
Mumbai Western Railway Commuters Face Severe Disruption For Weeks Amid Large-Scale Traffic Block
(With inputs from PTI)
